Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
MedPharm Ltd, a world-leading contract developer of topical and transdermal pharmaceutical products, is opening a new location in Raleigh-Durham, North Carolina that will expand its CDMO services in topical and transdermal delivery.
read more
Samsung Biologics, the world’s leading contract development and manufacturing organization, signed a strategic partnership with KAHR Medical Ltd., a cancer immunotherapy company developing novel multifunctional immune-recruitment proteins. Under the ...
read more
COREX Logistics announced the establishment of a representative office in Kazakhstan. Its office based in Almaty will serve the needs of international pharma and biotech conducting clinical research in the country.
read more
Berkshire Sterile Manufacturing (BSM), a small-scale sterile fill-finish operation located in Lee, Massachusetts, has installed a new, state-of-the-art filler in their semi-automated isolator-based filling line. The filler features a double-headed ...
read more
Samsung Biologics announced plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility in Songdo, ready for cGMP operations within the earlier part of the year in 2022. mRNA has been the technology of choice for ...
read more
BioVaxys announced that its bioproduction partner Bio Elpida of Lyon, France, has initiated the construction of a new Good Manufacturing Practice ("GMP") cleanroom facility needed for producing the clinical supply of BVX-0918A, BioVaxys' ovarian ...
read more
Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that it has entered into an additional agreement with Lonza to support drug substance manufacturing for its global supply chain. The agreement will ...
read more
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, will open its expanded production facilities in Ajdovscina, Slovenia. The area for manufacturing and labs will increase from 3,000 square meters ...
read more
The agreement with the U.S. Department of Health and Human Services, in coordination with the U.S. Department of Defense (DOD), will expand testing opportunities in K-8 schools, underserved populations and congregate settings such as homeless ...
read more
SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, will be commercially manufacturing and distributing PYLARIFY®(piflufolastat F 18) injection, an F 18-labeled prostate-specific membrane ...
read more
Aptamer Group, the developer of diagnostic and therapeutic Optimer™ reagents, announced that it has signed an agreement with the multinational pharmaceutical and biopharmaceutical company Takeda Pharmaceutical Company Limited (“Takeda”).
read more
August Bioservices,LLC, a contract development and manufacturing organization (CDMO) providing drug discovery, development, and pharmaceutical manufacturing services, closed a $23.6 million Series A extension, led by Polaris Partners, who joined ...
read more
ProBioGen and Minapharm Pharmaceuticals announce the incorporation of ProBioGen's subsidiary "MiGenTra" with headquarters in Berlin and access to a site in Cairo, which will house its principal manufacturing plant. MiGenTra will enhance the ...
read more
Inotiv, a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, announced that the Company has completed the purchase of its previously leased St. Louis facility for approximately $...
read more
Spaulding Clinical, a full-service Phase I clinical service provider, announced expanded services for clinical trial Phases I through III, including biometrics, data management, and medical writing. While approaching their 15th anniversary and ...
read more